Pubertal timing and incident ovarian cancer in the Sister Study cohort
Menée à partir de données de l'étude "the Sister Study" portant sur 40 809 femmes (durée médiane de suivi : 13,3 ans), cette étude analyse l'association entre l'âge de la ménarche, l'âge de la thélarche et le risque de cancer de l'ovaire (291 cas)
Background: Pubertal milestones such as menarche (first period) and thelarche (onset of breast development) are markers of hormonal changes that may be relevant to the hormonal etiology of ovarian cancer. Prior studies of the association of age at menarche with ovarian cancer risk have been inconsistent, while age at thelarche has not been examined in relation to ovarian cancer incidence.
Methods: With data from 40,809 women in the Sister Study, we used multivariable-adjusted Cox proportional hazards regression to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for associations of self-reported ages at thelarche and menarche with incident ovarian cancer, both overall and by histotype.
Results: During a median follow-up of 13.3 years, 291 women reported a diagnosis of ovarian cancer. Ages at thelarche (HR 0.94, 95% CI 0.87-1.02 per one-year older) and menarche (HR 0.99, 95% CI 0.91-1.07 per one-year older) were not associated with ovarian cancer overall. Although imprecise, HRs suggested a possible inverse association of ages at thelarche (HR 0.71, 95% CI 0.48-1.04) and menarche (HR 0.79, 95% CI 0.59-1.04) with incidence of clear cell tumors.
Conclusions: Ages at thelarche and menarche were not associated with ovarian cancer incidence overall.
Impact: Though our results do not provide clear evidence of associations of pubertal timing with ovarian cancer incidence, possible associations of earlier thelarche and menarche with increased incidence of ovarian clear cell carcinoma may warrant further investigation, especially considering secular trends towards earlier thelarche.
Cancer Epidemiology, Biomarkers & Prevention , résumé, 2025